Compressing drug development timelines in oncology using phase '0' trials

Overview of attention for article published in Nature Reviews Cancer, February 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)

Mentioned by

policy: 1 policy source

patent: 2 patents

Citations

dimensions_citation: 195 Dimensions

Readers on

mendeley: 374 Mendeley
citeulike: 1 CiteULike

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Biomarkers of therapeutic responsiveness

Grant US-11467161-B2

United States of America

Biomarkers of therapeutic responsiveness

Grant US-11105799-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.